By combining advanced vision-language AI models with real-world task analysis, researchers developed a system that can recognize cognitive sequencing errors during everyday activities like cooking. This approach moves beyond traditional assessments, offering a more realistic way to support safety, confidence, and daily functioning.
Research from WashU Medicine reports encouraging long-term results for tofersen, an FDA-approved therapy for a rare genetic form of ALS caused by SOD1 mutations. Extended treatment slowed disease progression and improved survival, with about one-quarter of participants experiencing stabilization or gains in strength and mobility.
Research at Washington University in St. Louis has been recognized on the global stage, with WashU named a Focused Ultrasound Center of Excellence by the Focused Ultrasound Foundation.
NEURO360-aligned research led by Rohit V. Pappu, PhD, with Min Kyung Shinn, PhD, at WashU’s McKelvey School of Engineering is uncovering new therapeutic targets for neurodegenerative disorders such as ALS.
ShiNung Ching, PhD, co-lead of NEURO360’s Mobile Apps, Software & Computing Research Node and a professor of neuroengineering, has been named chair of the Preston M. Green Department of Electrical & Systems Engineering at Washington University in St. Louis.
The Q4 edition of the NEURO360 newsletter highlights key findings from nine community listening sessions conducted across the St. Louis region in …
Over the past year, the NEURO360 team worked with its partner, the St. Louis Integrated Health Network (IHN) to host nine community …
NEURO360‑aligned research by Muriah D. Wheelock and Brian A. Gordon at WashU Medicine received a $5 million NIH grant to study how early‑life stress affects brain aging and Alzheimer’s.
By combining advanced vision-language AI models with real-world task analysis,...
Read More
Research from WashU Medicine reports encouraging long-term results for tofersen,...
Read More
Research at Washington University in St. Louis has been recognized...
Read More
NEURO360-aligned research led by Rohit V. Pappu, PhD, with Min...
Read More
ShiNung Ching, PhD, co-lead of NEURO360’s Mobile Apps, Software &...
Read More
The Q4 edition of the NEURO360 newsletter highlights key findings...
Read More
Over the past year, the NEURO360 team worked with its...
Read More
NEURO360‑aligned research by Muriah D. Wheelock and Brian A. Gordon...
Read More
NEURO360‑aligned research by Muriah D. Wheelock and Brian A. Gordon...
Read More
By combining advanced vision-language AI models with real-world task analysis, researchers developed a system that can recognize cognitive sequencing errors during everyday activities like cooking. This approach moves beyond traditional assessments, offering a more realistic way to support safety, confidence, and daily functioning.
Research from WashU Medicine reports encouraging long-term results for tofersen, an FDA-approved therapy for a rare genetic form of ALS caused by SOD1 mutations. Extended treatment slowed disease progression and improved survival, with about one-quarter of participants experiencing stabilization or gains in strength and mobility.
Research at Washington University in St. Louis has been recognized on the global stage, with WashU named a Focused Ultrasound Center of Excellence by the Focused Ultrasound Foundation.
NEURO360-aligned research led by Rohit V. Pappu, PhD, with Min Kyung Shinn, PhD, at WashU’s McKelvey School of Engineering is uncovering new therapeutic targets for neurodegenerative disorders such as ALS.
ShiNung Ching, PhD, co-lead of NEURO360’s Mobile Apps, Software & Computing Research Node and a professor of neuroengineering, has been named chair of the Preston M. Green Department of Electrical & Systems Engineering at Washington University in St. Louis.
The Q4 edition of the NEURO360 newsletter highlights key findings …
Over the past year, the NEURO360 team worked with its …
NEURO360‑aligned research by Muriah D. Wheelock and Brian A. Gordon at WashU Medicine received a $5 million NIH grant to study how early‑life stress affects brain aging and Alzheimer’s.
NEURO360‑aligned research by Muriah D. Wheelock and Brian A. Gordon at WashU Medicine received a $5 million NIH grant to study how early‑life stress affects brain aging and Alzheimer’s.
Lan Yang has been named one of the world’s most highly cited researchers by the Institute for Scientific Information, ranking among the top 1% in her field over the past decade.
Jeff Milbrandt, MD, PhD, has been awarded the inaugural WashU Medicine Dean’s Medal for Innovation and Commercialization, recognizing his transformative discoveries in neurodegeneration and his leadership in translating breakthrough science into therapies.
NEURO360 partner work led by Randall J. Bateman, MD, is advancing global Alzheimer’s prevention trials through WashU’s DIAN-TU, which is testing whether anti-amyloid antibody therapies can stop the disease before symptoms begin.